Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
"Having 40 extra pulses allows us to treat lesions that in the past might have been too diffuse or too long for single-catheter IVL use, and we also can use the extra pulses in the C2+ to treat lesions in more than one vessel," says Dr....
"Having 40 extra pulses allows us to treat lesions that in the past might have been too diffuse or too long for single-catheter IVL use, and we also can use the extra pulses in the C2+ to treat lesions in more than one vessel," says Dr....
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
Dr. Khatri is the Director of Complex Coronary Intervention at Cleveland Clinic, performing 150-200 chronic total occlusion (CTO) procedures annually, along with a high volume of complex and high-risk coronary intervention procedures (CHIP).
Dr. Khatri is the Director of Complex Coronary Intervention at Cleveland Clinic, performing 150-200 chronic total occlusion (CTO) procedures annually, along with a high volume of complex and high-risk coronary intervention procedures (CHIP).
The patient is an 86-year-old male with known coronary artery disease (CAD). Three years ago, he had robotic left internal mammary artery (LIMA) graft to the left anterior descending (LAD) and percutaneous coronary intervention (PCI) of the...
The patient is an 86-year-old male with known coronary artery disease (CAD). Three years ago, he had robotic left internal mammary artery (LIMA) graft to the left anterior descending (LAD) and percutaneous coronary intervention (PCI) of the...
This case highlights that rotational atherectomy is merely paving the road and may help in superficial calcifications. It also showed the useful role of optical coherence tomography (OCT) for guiding the appropriate treatment strategy....
This case highlights that rotational atherectomy is merely paving the road and may help in superficial calcifications. It also showed the useful role of optical coherence tomography (OCT) for guiding the appropriate treatment strategy....
A calcified nodule is an infrequent pathological substrate in acute coronary syndrome patients. This case demonstrates the technical challenges of intervening an eccentric, severely calcified, balloon-uncrossable coronary lesion.
A calcified nodule is an infrequent pathological substrate in acute coronary syndrome patients. This case demonstrates the technical challenges of intervening an eccentric, severely calcified, balloon-uncrossable coronary lesion.
Corrado Tamburino, MD, PhD, FESC, FSCAI; Alessio La Manna, MD; Guido D'Agosta, MD; Giuseppe Venuti, MD
Coronary lithoplasty is a promising technique that can overcome issues regarding the treatment of undilatable, heavily calcified, de novo, and in-stent restenotic lesions, allowing plaque modification and successful stent deployment, as...
Coronary lithoplasty is a promising technique that can overcome issues regarding the treatment of undilatable, heavily calcified, de novo, and in-stent restenotic lesions, allowing plaque modification and successful stent deployment, as...
Daniel Obaid, MBBCh, PhD; Alexander J. Chase, MBBCh, PhD, MBBS, MD; Dave Smith, BM, MD
3D-OCT revealed extensive fracture and distortion of the struts in the distal portion of a stent, presumably caused by aggressive postdilation at the time of implantation. This was managed successfully with the insertion of a new coronary...
3D-OCT revealed extensive fracture and distortion of the struts in the distal portion of a stent, presumably caused by aggressive postdilation at the time of implantation. This was managed successfully with the insertion of a new coronary...
Optimal stent deployment can become a challenge for the interventional cardiologist, especially when it involves calcified, undilatable lesions. Various technologies have been developed to tackle this scenario and the super high-pressure...
Optimal stent deployment can become a challenge for the interventional cardiologist, especially when it involves calcified, undilatable lesions. Various technologies have been developed to tackle this scenario and the super high-pressure...
Bernard Wong, MBChB; Aleksandar Cicovic, MBChB; Guy Armstrong, MBChB; Seif S. El-Jack, MBBS, MD
While traditional calcium modification devices like rotational atherectomy may have a role in treating concentric calcium, their role in eccentric calcium is unclear. Intravascular lithotripsy (IVL) (Shockwave Medical) is a newly available...
While traditional calcium modification devices like rotational atherectomy may have a role in treating concentric calcium, their role in eccentric calcium is unclear. Intravascular lithotripsy (IVL) (Shockwave Medical) is a newly available...
Pradnya Brijmohan Bhattad, MD; Joseph C. Hannan, MD, FACC
Drs. Bhattad and Hannan review coronary artery fistula management and identification, and share videos of a coronary artery fistula encountered as an incidental finding.
Drs. Bhattad and Hannan review coronary artery fistula management and identification, and share videos of a coronary artery fistula encountered as an incidental finding.
A 54-year-old male with a past medical history of Hodgkin’s lymphoma with previous chemo and radiation therapy 22 years ago and type II diabetes initially presented at an outlying hospital with acute onset dyspnea. An initial...
A 54-year-old male with a past medical history of Hodgkin’s lymphoma with previous chemo and radiation therapy 22 years ago and type II diabetes initially presented at an outlying hospital with acute onset dyspnea. An initial...
Deliverability of IVL devices can be challenging. Thankfully, the low-profile design coupled with increased pushability of Terumo’s Takeru™ PTCA Balloon Dilatation Catheter facilitates the use of IVL in heavily calcified lesions.
Deliverability of IVL devices can be challenging. Thankfully, the low-profile design coupled with increased pushability of Terumo’s Takeru™ PTCA Balloon Dilatation Catheter facilitates the use of IVL in heavily calcified lesions.
With an aging population, the need to modify severely calcified coronary lesions prior to stent deployment is as common and difficult as ever. In this case, we highlight the treatment strategy of a tight lesion in a large vessel that was...
With an aging population, the need to modify severely calcified coronary lesions prior to stent deployment is as common and difficult as ever. In this case, we highlight the treatment strategy of a tight lesion in a large vessel that was...
Yashwant Agrawal, MD, FACC, FSCAI; Dominika M. Zoltowska, MD; Anthony Elghoul; Anwita Reddy Nimma; Tim A. Fischell, MD, FACC, FSCAI
Spontaneous or trauma-related coronary intramural hematoma, a subset of coronary artery dissection, is a rare, challenging, and under-recognized diagnosis constituting 1% to 4% of all myocardial infarctions.(1)
Spontaneous or trauma-related coronary intramural hematoma, a subset of coronary artery dissection, is a rare, challenging, and under-recognized diagnosis constituting 1% to 4% of all myocardial infarctions.(1)
Pradnya Brijmohan Bhattad, MD; Anderson Ariaga, MD; Arnav Jain; Luigi Pacifico, DO
Pacemaker-mediated tachycardia (PMT) also known as endless loop tachycardia, is an iatrogenic arrhythmia that occurs primarily in patients with dual chamber pacemakers with at least atrial-sensing and ventricular pacing functions.
Pacemaker-mediated tachycardia (PMT) also known as endless loop tachycardia, is an iatrogenic arrhythmia that occurs primarily in patients with dual chamber pacemakers with at least atrial-sensing and ventricular pacing functions.
Case Report
A 45-year-old woman, who was a nonsmoker with a known case of hypertension, presented with a history of pain in her right upper limb on exertion for the past 6 months. There was no history of any neurological symptoms, trauma,...
Case Report
A 45-year-old woman, who was a nonsmoker with a known case of hypertension, presented with a history of pain in her right upper limb on exertion for the past 6 months. There was no history of any neurological symptoms, trauma,...
Drs. Bhattad and Pacifico share views of a rare coronary anomaly involving an anomalous left main coronary artery originating from the right sinus of Valsalva.
Drs. Bhattad and Pacifico share views of a rare coronary anomaly involving an anomalous left main coronary artery originating from the right sinus of Valsalva.
Sreejit Nair, MD; Ashwani Sastry, MD; Janardhan Srinivasan, MD; Michael Canavan, DPM; Fadi Saab, MD, FACC, FSCAI; John H. Rundback, MD, FAHA, FSIR
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Retrograde pedal access has been well-described in the literature to facilitate complex arterial revascularization when a traditional antegrade approach fails. This is useful for infrapopliteal disease that is often seen in patients with CLI.
Morton J. Kern, MD, MSCAI, FACC, FAHA; Arnold H. Seto, MD, MPA, CCDS, FACC, FSCAI; Bailey Ann Estes, AGNP-C, MSN, RN-BC, RCIS, RNFA
Drs Mort Kern and Arnold Seto, and Bailey Estes, AGNP-C, discuss the results of 4 trials presented at ACC.25 and how decision making in the cath lab will be affected by the trial results.
Drs Mort Kern and Arnold Seto, and Bailey Estes, AGNP-C, discuss the results of 4 trials presented at ACC.25 and how decision making in the cath lab will be affected by the trial results.
How can we design peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) trials that actually reflect the patients we treat every day? In his CRT 2025 presentation, Dr. Zola M. N'Dandu addressed the urgent need to...
How can we design peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI) trials that actually reflect the patients we treat every day? In his CRT 2025 presentation, Dr. Zola M. N'Dandu addressed the urgent need to...
At CRT 2025 in Washington, D.C., Dr. Morton J. Kern discussed his prediction around the FLAVOUR II trial: would AI-driven angioFFR prove to be noninferior to intravascular ultrasound (IVUS) in guiding percutaneous coronary intervention for...
At CRT 2025 in Washington, D.C., Dr. Morton J. Kern discussed his prediction around the FLAVOUR II trial: would AI-driven angioFFR prove to be noninferior to intravascular ultrasound (IVUS) in guiding percutaneous coronary intervention for...
Dr. Sacharias von Koch presented an analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) on the Prevail™ coronary paclitaxel drug-coated balloon (DCB) from Medtronic as a late-breaking clinical trial at...
Dr. Sacharias von Koch presented an analysis of data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) on the Prevail™ coronary paclitaxel drug-coated balloon (DCB) from Medtronic as a late-breaking clinical trial at...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...
Thomas E. Milner, PhD; Mehmet Cilingiroglu, MD, FSCAI, FACC, FESC, FAHA; Ibrahim Halil Inanc, MD
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
Dr. Thomas Milner, Dr. Mehmet Cilingiroglu, and Dr. Ibrahim Halil Inanc explore the emerging role of intravascular optical coherence tomography (OCT) in the treatment of peripheral arterial disease (PAD).
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
This 16-minute presentation by Bailey Estes, MSN, highlights essential calcium modification techniques and emphasizes the importance of intravascular imaging in guiding safe, effective, and durable interventions.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr Ramon Varcoe discusses his ISET 2025 presentation on the efficacy and safety of bioresorbable drug-coated balloons in treating infrapopliteal arterial disease.
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy
Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy
Transformative Technology Now Available for Calcified Coronary Plaque
SANTA CLARA, Calif., Feb. 16, 2021 — Shockwave Medical, Inc. announced today that the company’s sonic pressure wave therapy received Pre-Market Approval for severely...
Transformative Technology Now Available for Calcified Coronary Plaque
SANTA CLARA, Calif., Feb. 16, 2021 — Shockwave Medical, Inc. announced today that the company’s sonic pressure wave therapy received Pre-Market Approval for severely...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease
Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease
Medtronic, the global leader in health care technology, today announced the primary and...
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Camzyos is an FDA-approved cardiac myosin inhibitor for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II-III obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.(1)
Data From the Disrupt CAD Clinical Program Demonstrate Consistency of Shockwave IVL Outcomes Over Time, Across Calcium Morphologies and Between Genders
Data From the Disrupt CAD Clinical Program Demonstrate Consistency of Shockwave IVL Outcomes Over Time, Across Calcium Morphologies and Between Genders
Information from the past five years of intravascular imaging at St. Francis Hospital, thousands of cases, has allowed us to develop algorithms or workflows for approaching stent implantation, which has been particularly helpful when...
Information from the past five years of intravascular imaging at St. Francis Hospital, thousands of cases, has allowed us to develop algorithms or workflows for approaching stent implantation, which has been particularly helpful when...
To assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions.
To assess the clinical and angiographic outcomes of coronary intravascular lithotripsy use in an all-comers population with moderate-to-severely calcified coronary lesions.
James D. Flaherty, MD; Keith H. Benzuly, MD; Daniel R. Schimmel, MD, MS; Brett B. Yarusi, MD; Vikrant S. Jagadeesan, MD; Arif Jivan, MD, PhD; Erin D. Unger, MD; Lowie M.R. Van Assche, MD; Tim S. Provias, MD, MPH
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
We performed a retrospective review of patients who were excluded from preapproval trials of coronary IVL and underwent CAC modification with the off-label use of a peripheral IVL system.
Stefan Blankenberg, MD; Fabian J. Brunner, MD; Peter Moritz Becher, MD; Christoph Waldeyer, MD; Elvin Zengin-Sahm, MD; Renate B. Schnabel, MD; Peter Clemmensen, MD; Dirk Westermann, MD; Moritz Seiffert, MD
Richard A. Shlofmitz, MD; Evan Shlofmitz, DO; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; Seung-Woon Rha, MD, PhD
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
OA is an effective tool to modify calcified plaque prior to stenting. However, advancement of the OA crown may be technically challenging due to complex coronary anatomy. We report our initial experience with GlideAssist to facilitate...
Bernard Wong, MBChB; Aleksandar Cicovic, MBChB; Guy Armstrong, MBChB; Seif S. El-Jack, MBBS, MD; Ruth Newcombe; Timothy Glenie, MBChB; Ali Khan, MBBS, MD
We present the first cases of Shockwave intravascular lithotripsy (Shockwave Medical), a novel coronary calcium modification device, being used in patients undergoing PCI for STEMI.
We present the first cases of Shockwave intravascular lithotripsy (Shockwave Medical), a novel coronary calcium modification device, being used in patients undergoing PCI for STEMI.
Rotational atherectomy (RA) is a useful tool for modification of calcified plaque prior to PCI. We report our experience with RA for severely calcified left main coronary artery disease.
Rotational atherectomy (RA) is a useful tool for modification of calcified plaque prior to PCI. We report our experience with RA for severely calcified left main coronary artery disease.
Richard A. Shlofmitz, MD; Evan Shlofmitz, DO; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; John Hollowed, MD; Kyung Woo Park, MD; Gentian Lluri, MD, PhD
Orbital atherectomy of long, diffusely calcified lesions may increase the risk of periprocedural angiographic complications. The aim of this study was to determine the clinical outcomes of patients with long, diffusely calcified coronary...
Orbital atherectomy of long, diffusely calcified lesions may increase the risk of periprocedural angiographic complications. The aim of this study was to determine the clinical outcomes of patients with long, diffusely calcified coronary...
Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; Neal Shah, MD
The presence of coronary artery calcium (CAC) is indicative of advanced coronary artery disease. We discuss the implications of CAC on outcomes during and after PCI as well as interventional strategies used for the successful treatment of...
The presence of coronary artery calcium (CAC) is indicative of advanced coronary artery disease. We discuss the implications of CAC on outcomes during and after PCI as well as interventional strategies used for the successful treatment of...
The authors review demographic and clinical characteristics, and short-intermediate term outcomes of patients presenting to a safety-net hospital with peripheral arterial disease treated with directional atherectomy and drug-coated balloon...
The authors review demographic and clinical characteristics, and short-intermediate term outcomes of patients presenting to a safety-net hospital with peripheral arterial disease treated with directional atherectomy and drug-coated balloon...
The Centers for Medicare & Medicaid Services (CMS) recently released its 2025 updates, introducing significant changes to the Medicare payment systems that will impact healthcare providers nationwide.
The Centers for Medicare & Medicaid Services (CMS) recently released its 2025 updates, introducing significant changes to the Medicare payment systems that will impact healthcare providers nationwide.
Richard J. Merschen, EdS, RT(R)(CV), RCIS1; Madalynne Ruth, RT/ICVT student2 1Philadelphia, Pennsylvania; 2Thomas Jefferson College of Health Professions, Philadelphia, Pennsylvania
Richard J. Merschen, EdS, RT(R)(CV), ...
Waveform capnography is a continuous, non-invasive measurement of a patient’s ventilation effort and measures the amount of carbon dioxide (CO2) in exhaled air. It consists of two major elements: capnometry and waveform capnography.
Waveform capnography is a continuous, non-invasive measurement of a patient’s ventilation effort and measures the amount of carbon dioxide (CO2) in exhaled air. It consists of two major elements: capnometry and waveform capnography.
Deniz Mutlu, MD; Athanasios Rempakos, MD; Michaella Alexandrou, MD; Ahmed Al-Ogaili, MD; Bavana V. Rangan, BDS, MPH; Olga C. Mastrodemos, BA; Yader Sandoval, MD; M. Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD
Deniz Mutlu, MD; Athanasios Rempakos,...
The authors examined the contemporary trends and determinants of radiation dose in the PROGRESS CTO registry.
The authors examined the contemporary trends and determinants of radiation dose in the PROGRESS CTO registry.
It is anticipated that by 2030, 82% of all outpatient cardiovascular procedures will be appropriate for migration from the hospital to an ambulatory surgery center (ASC).(1) What will that ASC look like?
It is anticipated that by 2030, 82% of all outpatient cardiovascular procedures will be appropriate for migration from the hospital to an ambulatory surgery center (ASC).(1) What will that ASC look like?
The authors describe an in-house study of their new practice standard, as prescribed by the RAVE trial, which combines a hemostasis pad (SoftSeal-STF [Chitogen]) with short-term use of a radial compression device to achieve hemostasis in a...
The authors describe an in-house study of their new practice standard, as prescribed by the RAVE trial, which combines a hemostasis pad (SoftSeal-STF [Chitogen]) with short-term use of a radial compression device to achieve hemostasis in a...
This year’s TCT Shark Tank Innovation Competition featured six companies presenting their technologies, chosen from over 50 submissions. TCT partnered with the Jon DeHaan Foundation to provide a $200,000 award to the 2023 competition winner,...
This year’s TCT Shark Tank Innovation Competition featured six companies presenting their technologies, chosen from over 50 submissions. TCT partnered with the Jon DeHaan Foundation to provide a $200,000 award to the 2023 competition winner,...
Even though crossing aortic valves isn’t a lost art, crossing may be more difficult for novice operators because of a lack of everyday practice in the cath lab.
Even though crossing aortic valves isn’t a lost art, crossing may be more difficult for novice operators because of a lack of everyday practice in the cath lab.
Zainali S. Chunawala, MD; Christopher Chew, MD; Michael Hendrickson, MD; Sameer Arora, MD; Alfonso Tafur, MD, MS, MBA
Temporal trends in prevalence of significant CAD (history of myocardial infarction or coronary revascularizations) in hospitalizations for CLTI were determined using the 2000 to 2018 National Inpatient Sample (NIS) database. A multivariable...
Temporal trends in prevalence of significant CAD (history of myocardial infarction or coronary revascularizations) in hospitalizations for CLTI were determined using the 2000 to 2018 National Inpatient Sample (NIS) database. A multivariable...
This quiz is based on an interview with Kevin J. Croce, MD, PhD. Read "Image-Guided Calcium Modification: IVL."
CLD March 2022 Calcium Corner QuizDr. Croce describes an image-based strategy that involves an algorithm called...
This quiz is based on an interview with Kevin J. Croce, MD, PhD. Read "Image-Guided Calcium Modification: IVL."
CLD March 2022 Calcium Corner QuizDr. Croce describes an image-based strategy that involves an algorithm called...
This quiz is based on an interview with Margaret McEntegart, BSc (Hons), MBChB, MRCP (UK), PhD.
Read "Data Show Coronary Intravascular Lithotripsy is Safe, Effective, and Cost Efficient."
CLD Jan 2021 Calcium...
This quiz is based on an interview with Margaret McEntegart, BSc (Hons), MBChB, MRCP (UK), PhD.
Read "Data Show Coronary Intravascular Lithotripsy is Safe, Effective, and Cost Efficient."
CLD Jan 2021 Calcium...
This quiz is based on interviews with Drs. Dean Kereiakes, Ziad Ali, Akiko Maehara, and Yasin Hussain.
Read "Coronary Intravascular Lithotripsy (IVL): Research Roundup at TCT."
[COPY] TCT Roundup Dec 2021 Calcium...
This quiz is based on interviews with Drs. Dean Kereiakes, Ziad Ali, Akiko Maehara, and Yasin Hussain.
Read "Coronary Intravascular Lithotripsy (IVL): Research Roundup at TCT."
[COPY] TCT Roundup Dec 2021 Calcium...
This quiz is based on an interview and case report from Srini Potluri, MD, FACC, FSCAI.
Read "Safe and Effective Calcium Modification in Severe Ostial Right Coronary Artery Stenosis."
Potluri CLD Nov 2021 Calcium Corner...
This quiz is based on an interview and case report from Srini Potluri, MD, FACC, FSCAI.
Read "Safe and Effective Calcium Modification in Severe Ostial Right Coronary Artery Stenosis."
Potluri CLD Nov 2021 Calcium Corner...
This quiz is based on an interview with Andrew J.P. Klein, MD, FACC, FSVM, FSCAI. Click here to read "Coronary IVL Tips and Tricks."
Klein CLD Oct 2021 Calcium Corner QuizIntravascular lithoplasty has eliminated the need for coronary...
This quiz is based on an interview with Andrew J.P. Klein, MD, FACC, FSVM, FSCAI. Click here to read "Coronary IVL Tips and Tricks."
Klein CLD Oct 2021 Calcium Corner QuizIntravascular lithoplasty has eliminated the need for coronary...
This quiz is based on an interview with Evan Shlofmitz, DO. Click here to read "When to Use IVL: An Exploration of Treatment Algorithms".
Shlofmitz CLD Sept 2021 Calcium Corner QuizIf you can cross with an OCT or IVUS...
This quiz is based on an interview with Evan Shlofmitz, DO. Click here to read "When to Use IVL: An Exploration of Treatment Algorithms".
Shlofmitz CLD Sept 2021 Calcium Corner QuizIf you can cross with an OCT or IVUS...
This quiz is based on an interview with Nadia Sutton, MD. Click here to read "The Impact of Calcium on PCI and the Need for Intravascular Lithotripsy (IVL)".
Intravascular lithotripsy (IVL) uses sonic pressure waves to fracture both...
This quiz is based on an interview with Nadia Sutton, MD. Click here to read "The Impact of Calcium on PCI and the Need for Intravascular Lithotripsy (IVL)".
Intravascular lithotripsy (IVL) uses sonic pressure waves to fracture both...
This quiz is based on an interview with Kevin J. Croce, MD, PhD. Read "Image-Guided Calcium Modification: IVL."
CLD March 2022 Calcium Corner QuizDr. Croce describes an image-based strategy that involves an algorithm called...
This quiz is based on an interview with Kevin J. Croce, MD, PhD. Read "Image-Guided Calcium Modification: IVL."
CLD March 2022 Calcium Corner QuizDr. Croce describes an image-based strategy that involves an algorithm called...
This quiz is based on an interview with Margaret McEntegart, BSc (Hons), MBChB, MRCP (UK), PhD.
Read "Data Show Coronary Intravascular Lithotripsy is Safe, Effective, and Cost Efficient."
CLD Jan 2021 Calcium...
This quiz is based on an interview with Margaret McEntegart, BSc (Hons), MBChB, MRCP (UK), PhD.
Read "Data Show Coronary Intravascular Lithotripsy is Safe, Effective, and Cost Efficient."
CLD Jan 2021 Calcium...
This quiz is based on interviews with Drs. Dean Kereiakes, Ziad Ali, Akiko Maehara, and Yasin Hussain.
Read "Coronary Intravascular Lithotripsy (IVL): Research Roundup at TCT."
[COPY] TCT Roundup Dec 2021 Calcium...
This quiz is based on interviews with Drs. Dean Kereiakes, Ziad Ali, Akiko Maehara, and Yasin Hussain.
Read "Coronary Intravascular Lithotripsy (IVL): Research Roundup at TCT."
[COPY] TCT Roundup Dec 2021 Calcium...
This quiz is based on an interview and case report from Srini Potluri, MD, FACC, FSCAI.
Read "Safe and Effective Calcium Modification in Severe Ostial Right Coronary Artery Stenosis."
Potluri CLD Nov 2021 Calcium Corner...
This quiz is based on an interview and case report from Srini Potluri, MD, FACC, FSCAI.
Read "Safe and Effective Calcium Modification in Severe Ostial Right Coronary Artery Stenosis."
Potluri CLD Nov 2021 Calcium Corner...
This quiz is based on an interview with Andrew J.P. Klein, MD, FACC, FSVM, FSCAI. Click here to read "Coronary IVL Tips and Tricks."
Klein CLD Oct 2021 Calcium Corner QuizIntravascular lithoplasty has eliminated the need for coronary...
This quiz is based on an interview with Andrew J.P. Klein, MD, FACC, FSVM, FSCAI. Click here to read "Coronary IVL Tips and Tricks."
Klein CLD Oct 2021 Calcium Corner QuizIntravascular lithoplasty has eliminated the need for coronary...
This quiz is based on an interview with Evan Shlofmitz, DO. Click here to read "When to Use IVL: An Exploration of Treatment Algorithms".
Shlofmitz CLD Sept 2021 Calcium Corner QuizIf you can cross with an OCT or IVUS...
This quiz is based on an interview with Evan Shlofmitz, DO. Click here to read "When to Use IVL: An Exploration of Treatment Algorithms".
Shlofmitz CLD Sept 2021 Calcium Corner QuizIf you can cross with an OCT or IVUS...
This quiz is based on an interview with Nadia Sutton, MD. Click here to read "The Impact of Calcium on PCI and the Need for Intravascular Lithotripsy (IVL)".
Intravascular lithotripsy (IVL) uses sonic pressure waves to fracture both...
This quiz is based on an interview with Nadia Sutton, MD. Click here to read "The Impact of Calcium on PCI and the Need for Intravascular Lithotripsy (IVL)".
Intravascular lithotripsy (IVL) uses sonic pressure waves to fracture both...
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
Cath lab managers, administrators, and people looking at the overheads should be aware of this change because it is going to alter the landscape. If you are doing a complex case using multiple devices, there is no longer the potential for a...
"Having 40 extra pulses allows us to treat lesions that in the past might have been too diffuse or too long for single-catheter IVL use, and we also can use the extra pulses in the C2+ to treat lesions in more than one vessel," says Dr....
"Having 40 extra pulses allows us to treat lesions that in the past might have been too diffuse or too long for single-catheter IVL use, and we also can use the extra pulses in the C2+ to treat lesions in more than one vessel," says Dr....
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
In the patient-level pooled analysis, titled “Coronary Intravascular Lithotripsy for Treatment of Severely Calcified Lesions: Long-Term Sex-Specific Outcomes,” use of IVL for lesion preparation of severely calcified lesions had similar safety...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
SANTA CLARA, Calif.- Shockwave Medical, Inc. announced that as part of the Calendar Year 2024 Physician Fee Schedule (PFS) final rule, the U.S. Centers for Medicare & Medicaid Services (CMS) has established a Category I Current Procedural...
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Three new codes, MS-DRGs 323, 324, and 325, have been created to describe Percutaneous Coronary Interventions (PCI) that utilize coronary IVL, with and without a stent implant (intraluminal device), in the hospital inpatient setting.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
Shockwave C2+ provides 50 percent more pulses per catheter than Shockwave C2 and is optimally designed to treat longer calcified lesions and more challenging eccentric and nodular calcium.
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Rampart IC, a medical technology company developing market-leading radiation safety and orthopedic protection solutions for the interventional suite, announced the successful completion of its $21.6M Series B financing round. The round was...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease
Medtronic, the global leader in health care technology, today announced the primary and...
Results from study indicate strong healing rate of chronic venous ulcers when VenaSeal™ is used in patients with advanced superficial venous disease
Medtronic, the global leader in health care technology, today announced the primary and...
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.
Whether you’re focused on clinical care, innovation, or training the next generation, there’s something here to support your clinical, research, and career goals,” said SCAI President James B. Hermiller, MD, MSCAI.
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
This document draws on global clinical data and real-world evidence to evaluate the impact of a cardiac ablation SDD strategy on patient safety, access, operational efficiencies, and healthcare costs. It also outlines best practices based on...
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
“If you have a heart attack in the morning, you are more likely to have fatal arrhythmias, heart failure, and you’re more likely to die from it. The question we asked is ‘Why?’” said Holger Eltzschig, MD, PhD.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
Using the model to analyze patients’ ECG results could allow cardiologists to prioritize the highest-risk patients to bring them in sooner for an appointment and treatment before symptoms begin or exacerbate.
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
EFEMORAL I is a first-in-human clinical trial evaluating the performance of the Efemoral Vascular Scaffold System (EVSS) for the treatment of patients suffering symptomatic peripheral arterial occlusive disease from atherosclerosis of the...
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The PerQseal® Elite vascular closure system is a sutureless and fully bioresorbable large-bore vessel closure device. The company plans to launch the product in select European markets this summer.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
The first patient in its ELITE-BTK pivotal trial was treated by Dr. Brian DeRubertis, FACS, Chief of the Division of Vascular & Endovascular Surgery at NewYork-Presbyterian and Weill Cornell Medicine in New York City.
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
“Patients at higher risk for mortality and morbidity associated with high blood pressure are the core of the population we are actively enrolling in the BACKBEAT global pivotal study of hypertensive pacemaker-indicated patients in...
